Cancer Research UK scheme secures £280m buy-in with Standard Life

BPA deal secures the benefits of 2,800 scheme members

Holly Roach
clock • 2 min read
Cancer Research UK scheme secures £280m buy-in with Standard Life

The Cancer Research UK Pension Scheme has completed a £280m buy-in deal with Standard Life.

The bulk purchase annuity (BPA) transaction – completed in March using a "bespoke offering" – secures the benefits of 2,800 scheme members. Mercer was lead transaction adviser to the trustee, wh...

To continue reading this article...

Join Professional Pensions

Become a Professional Pensions Lite Member today

  • Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
  • Receive important and breaking news stories via our two daily news alerts
  • Hear from industry experts and other forward-thinking leaders

Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here

Join now

 

Already a Professional Pensions
member?

Login

More on Risk Reduction

£175bn DB surplus recorded last month, according to PwC

£175bn DB surplus recorded last month, according to PwC

Low Reliance Index which tracks 5,000 corporate DB schemes measured 119% funding ratio

Jasmine Urquhart
clock 10 July 2025 • 2 min read
FTSE 100 scheme surpluses hold firm at £50bn, LCP finds

FTSE 100 scheme surpluses hold firm at £50bn, LCP finds

LCP analysis sees funding levels at 118% as endgame developments ‘continue at pace’

Jasmine Urquhart
clock 10 July 2025 • 1 min read
Rothesay completes £400m refinancing for Unite Group

Rothesay completes £400m refinancing for Unite Group

Loan secured against a portfolio of 23 PBSA assets located across 15 cities in the UK

Jonathan Stapleton
clock 09 July 2025 • 1 min read
Trustpilot